Molecular characterisation of potential vaccine candidates from Anaplasma marginale strains in South Africa

“…Further costs are attributable to chemotherapeutic treatment and tick control using acaricides. …”
Get full text

Development and Characterization of a Modified Vaccinia Ankara Vaccine Candidate Expressing the SARS-CoV-2 Spike Glycoprotein by Khumalo, Fezokuhle Ncedile

“…Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, SARS-CoV-2. Given the ongoing COVID-19 pandemic and the continued evolution of the virus to escape host immunity, new vaccines and refinement of first-generation vaccines to improve protection against SARS-CoV-2 variants of concern is vital. …”
Get full text

Genetic diversity of Anaplasma marginale in cattle and in putative novel Anaplasma species from wildlife in Mpumalanga, South Africa

Get full text